1. Piperacillin/tazobactam continuous infusion at 12G/1
Piperacillin/tazobactam continuous infusion at 12G/1.5G per day in CF patients results in target plasma-concentrations 
Kristina Öbrink-Hansen, Søren Jensen-Fangel, Birgitte Brock, Tore Forsingdal Hardlei, Anna Adelfred, Yousef Nejatbakhsh, Marianne Kragh Thomsen, Eskild Petersen 
Journal of Cystic Fibrosis 
Volume 15, Issue 2, Pages e13-e14 (March 2016)
DOI: /j.jcf
Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
Piperacillin plasma-concentrations for each patient throughout the treatment period. (A): Plasma-concentrations for patients receiving piperacillin continuous infusion 16g/day. (B): Plasma-concentrations for patients receiving piperacillin continuous infusion 12g/day.
Journal of Cystic Fibrosis  , e13-e14DOI: ( /j.jcf )
Copyright © 2015 European Cystic Fibrosis Society. Terms and Conditions